Loading provider…
Loading provider…
Cardiovascular Disease Physician in Plattsburgh, NY
NPI: 1184637233Primary Practice Location
CHAMPLAIN VALLEY PHYSICIANS HOSP MED CTR S N F
75 BEEKMAN STREET, Plattsburgh, NY
Primary Employer
Champlain Valley Physicians Hospital Medical Center
cvph.org
HQ Phone
Get DO Christopher's Phone Numberphone_androidMobile
Get DO Christopher's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
Geisinger Health System
fellowship • Cardiovascular Disease
2001 - 2004
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 93010Routine electrocardiogram (EKG) using at least 12 leads with interpretation and report | 1,775 | 2,385 |
| 2 | 93306Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | 600 | 617 |
| 3 | 99214Established patient office or other outpatient visit, 30-39 minutes | 376 | 518 |
| 4 | 93356Heart muscle strain imaging | 265 | 270 |
| 5 | 93018Exercise or drug-induced heart and blood vessel stress test with EKG monitoring, physician interpretation and report | 185 | 186 |
Authors: Phillip Smith, Matthew Mccarthy, Jane Ohalloran, Radica Alicic, Phillip Smith, Samuel Bozzette, Cameron Wolfe, Daniel Benjamin, Tatyana Der, Thomas Patterson, Christopher Palma, William Powderly, Eyal Kedar, Luis Parra-Rodriguez, Ave Lachiewicz
Journal: JAMA
Abatacept for Treatment of Adults Hospitalized with Moderate or Severe Covid-19.
Authors: Phillip Smith, Jane Ohalloran, Phillip Smith, Samuel Bozzette, Daniel Benjamin, Tatyana Der, Thomas Patterson, Christopher Palma, William Powderly, Eyal Kedar, Luis Parra-Rodriguez, Alfredo Mena Lora, Ave Lachiewicz
Journal: medRxiv
Publication Date: 2022-09-26
Lead Sponsor: Daniel Benjamin
Collaborators: National Center for Advancing Translational Sciences (NCATS), Biomedical Advanced Research and Development Authority
Intervention / Treatment: DRUG: Infliximab, DRUG: Remdesivir, DRUG: Abatacept, DRUG: cenicriviroc (closed to enrollment as of 3-Sep-2021)